Dr. Sonika Chibh is a postdoctoral fellow at Tel Aviv University, Israel. She obtained her B.Tech. in biotechnology degree from Jaypee University of Information Technology, Solan, Himachal Pradesh in 2014, and her master’s (M.Tech.) in biotechnology from Thapar University, Patiala, Punjab in 2016. She then received her Ph.D. in 2022 from the Indian Institute of Science Education and Research/ Institute of Nanoscience and Technology Mohali, Punjab. Her Ph.D. work focused on the formation of self-assembled peptide-based nanoparticles as a drug delivery system in cancer therapy. Her postdoctoral research at Tel Aviv University focused on the development of monoclonal antibodies against phenylalanine for the treatment of phenylketonuria, with Teva Pharmaceutical Industries Ltd.
Dr. Sonika Chibh has published several research articles in recognized international journals during her Ph.D. and postdoctoral studies. She received a George S. Wise Post-doctoral fellowship at Tel Aviv University in 2022. During her Ph.D. she received the Young Researcher award in an oral presentation organized by SYBS in 2021. She also received the Best Poster award in Bengaluru Nano in 2022.
As a Fulbright-Nehru Postdoctoral Research fellow at the Massachusetts Institute of Technology, Cambridge, Dr. Chibh is working on a project entitled “Design of Chemokine-Based Self-Assembled Nanoparticles for Receptor-mediated Specific Drug Delivery”. This project is in collaboration with Dr. Shuguang Zhang and MIT Institute Professor Robert Langer, who is the father of controlled drug delivery.